Arctic Bioscience Valuation Multiples

Arctic Bioscience Overview

About Arctic Bioscience

Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company’s proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. The company is developing a novel, oral drug candidate (HRO350) for the treatment of mild-to-moderate psoriasis. The company operates geographically in Norway, Americas, Europe, and APAC, with majority of the revenue deriving from Europe.

Founded

2011

HQ

Employees

25

Website

arctic-bioscience.com

Sectors

Nutraceuticals & CosmeceuticalsBioTech

Financials (FY)

Revenue: $5M

EBITDA: ($4M)

EV

$15M

Valuation Multiples

Multiples.vc

Start free trial

Arctic Bioscience Financials

Arctic Bioscience reported last fiscal year revenue of $5M and negative EBITDA of ($4M).

In the same fiscal year, Arctic Bioscience generated $1M in gross profit, ($4M) in EBITDA losses, and had net loss of ($5M).

Arctic Bioscience P&L

In the most recent fiscal year, Arctic Bioscience reported revenue of $5M and EBITDA of ($4M).

Arctic Bioscience expects next 12-month revenue of XXX and NTM EBITDA of XXX

Arctic Bioscience Stock Performance

Arctic Bioscience has current market cap of $9M, and enterprise value of $15M.

Arctic Bioscience's stock price is $0.34.

Arctic Bioscience Valuation Multiples

Arctic Bioscience trades at 3.3x EV/Revenue multiple, and (3.6x) EV/EBITDA.

Arctic Bioscience Financial Valuation Multiples

As of March 21, 2026, Arctic Bioscience has market cap of $9M and EV of $15M.

Equity research analysts estimate Arctic Bioscience's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Arctic Bioscience has a P/E ratio of (1.9x).

Arctic Bioscience Margins & Growth Rates

Arctic Bioscience's revenue in the last fiscal year grew by 29%.

Arctic Bioscience Public Comps

See public comps and valuation multiples for other Nutraceuticals & Cosmeceuticals comps.

Arctic Bioscience M&A Activity

Arctic Bioscience acquired XXX companies to date.

Last acquisition by Arctic Bioscience was on XXXXXXXX, XXXXX. Arctic Bioscience acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Arctic Bioscience Investment Activity

Arctic Bioscience invested in XXX companies to date.

Arctic Bioscience made its latest investment on XXXXXXXX, XXXXX. Arctic Bioscience invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).